Category: Uncategorized

February 4, 2020 – “Commercializing innovation for cancer patients and economic impact”, February 4, 2020

January 13, 2020 – January 13, 2020 – The financing enables the company to continue leveraging strong Ontario science, as well as develop manufacturing and local career opportunities for scientists and trainees

December 19, 2019 – December 19, 2019 – The strategic collaboration will focus on developing multiple products from Turnstone’s next-gen oncolytic viral immunotherapies, marking an important alliance for both companies in the fight against cancer.

December 5, 2019 – December 5, 2019 – The $1M award will support Dr. Pugh’s development work towards advancing a blood-based diagnostic for early cancer detection, in collaboration with Dr. Raymond Kim of the Princess Margaret Cancer Centre.

November 8, 2019 – November 8, 2019 – Titled “Ontario First in the innovation economy: impacts of a $1B USD public-private-partnership (PPP) on Canadian healthcare commercialization”, the panel seeks to highlight the outcomes and key lessons from this unprecedented partnership.

November 6, 2019 – November 6, 2019 – Scaling FACIT’s impact requires new partners and expanded expertise in the management of investments and equity markets. To that end, FACIT has recruited two seasoned executives through its Executive-in-Residence (EIR) Program.

October 30, 2019 – October 30, 2019 – Cellular Analytics is founded upon a proprietary microfluidic platform that enables molecular characterization of cancer at the level of single circulating tumour cells.

October 24, 2019 – October 24, 2019 – New partnership will provide the Ontario-based start up with both capital and advanced manufacturing expertise to accelerate its portable multi-energy x-ray detector technology.

September 26, 2019 – September 26, 2019 – FACIT announces investments in Xpan Inc. and innovations from OICR and the University of Toronto

August 8, 2019 – August 8, 2019 – New collaboration will develop targeted next generation sequencing (NGS) assays and software to improve cancer management